Bristol-Myers Squibb PE Ratio 2006-2019 | BMY

Current and historical p/e ratio for Bristol-Myers Squibb (BMY) from 2006 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Bristol-Myers Squibb PE ratio as of September 18, 2019 is 11.54.
Bristol-Myers Squibb PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-09-18 49.86 13.12
2019-06-30 45.35 $3.80 11.93
2019-03-31 47.71 $3.16 15.10
2018-12-31 51.51 $3.03 17.00
2018-09-30 61.13 $0.88 69.46
2018-06-30 54.11 $0.23 235.24
2018-03-31 61.44 $0.56 109.72
2017-12-31 59.15 $0.59 100.25
2017-09-30 61.15 $2.54 24.07
2017-06-30 53.09 $2.75 19.30
2017-03-31 51.43 $2.88 17.86
2016-12-31 54.91 $2.65 20.72
2016-09-30 50.31 $2.04 24.66
2016-06-30 68.63 $1.74 39.44
2016-03-31 59.30 $0.97 61.13
2015-12-31 63.48 $0.97 65.44
2015-09-30 54.33 $1.06 51.26
2015-06-30 60.36 $1.07 56.41
2015-03-31 58.17 $1.35 43.09
2014-12-31 53.24 $1.20 44.36
2014-09-30 45.55 $1.63 27.94
2014-06-30 42.85 $1.62 26.45
2014-03-31 45.57 $1.74 26.19
2013-12-31 46.62 $1.55 30.08
2013-09-30 40.02 $1.67 23.97
2013-06-30 38.34 $0.82 46.76
2013-03-31 35.04 $0.88 39.82
2012-12-31 27.43 $1.15 23.85
2012-09-30 28.12 $1.09 25.80
2012-06-30 29.67 $2.08 14.26
2012-03-31 27.58 $2.22 12.42
2011-12-31 28.51 $2.15 13.26
2011-09-30 25.13 $1.93 13.02
2011-06-30 23.19 $1.92 12.08
2011-03-31 20.93 $1.93 10.84
2010-12-31 20.45 $1.79 11.42
2010-09-30 20.94 $5.57 3.76
2010-06-30 19.04 $5.50 3.46
2010-03-31 20.12 $5.46 3.69
2009-12-31 18.80 $5.35 3.51
2009-09-30 16.56 $1.92 8.63
2009-06-30 14.51 $2.73 5.32
2009-03-31 15.45 $2.62 5.90
2008-12-31 16.38 $2.63 6.23
2008-09-30 14.28 $1.95 7.32
2008-06-30 13.86 $1.09 12.71
2008-03-31 14.17 $1.07 13.24
2007-12-31 17.44 $1.09 16.00
2007-09-30 18.77 $1.07 17.55
2007-06-30 20.38 $0.81 25.16
2007-03-31 17.74 $0.79 22.46
2006-12-31 16.65 $0.80 20.81
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $81.363B $22.561B
Bristol-Myers Squibb is a differentiated company, led by their unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. They work every day to deliver innovative medicines for patients with serious and life-threatening diseases. Their employees around the world work together for patients - it drives everything they do. They are focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience and fibrosis. Through their R&D organization, they have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate their work.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $342.221B 14.90
Roche Holding AG (RHHBY) Switzerland $240.930B 0.00
Merck (MRK) United States $211.257B 17.37
Pfizer (PFE) United States $201.883B 11.89
Novartis AG (NVS) Switzerland $198.525B 17.07
Novo Nordisk (NVO) Denmark $120.697B 21.33
AstraZeneca (AZN) United Kingdom $113.163B 21.89
Sanofi (SNY) France $110.933B 13.63
Eli Lilly (LLY) United States $107.279B 20.02
AbbVie (ABBV) United States $105.859B 8.48
GlaxoSmithKline (GSK) United Kingdom $102.512B 12.88
Bayer (BAYRY) Germany $69.195B 10.08
H Lundbeck (HLUYY) Denmark $6.741B 9.73